One tool that could help is a little-discussed law that allows the FDA to issue a voucher to speed drug development. Proposed by David Ridley at Duke University and colleagues, and adopted with bipartisan support in 2007, the voucher gives priority review for drugs that target neglected diseases.
Read Full Article »
